Introduction to Paxlovid (Nirmatrelvir + Ritonavir) 150mg+100mg
Paxlovid (Nirmatrelvir + Ritonavir) 150mg+100mg is a prescription antiviral medicine used for the treatment of mild-to-moderate COVID-19 in selected high-risk patients. It is designed to help reduce the risk of progression to severe illness, hospitalization, or death when started early after diagnosis.
Paxlovid (Nirmatrelvir + Ritonavir) 150mg+100mg is classified under Prescription Medicines, Antiviral Medicines, COVID-19 Treatment, and Oral Antiviral Therapies. It contains two active ingredients: Nirmatrelvir, which blocks SARS-CoV-2 viral replication, and Ritonavir, which helps increase the effectiveness of Nirmatrelvir by slowing its breakdown in the body.
In Bangladesh, Bexovid 150mg+100mg is available as a local brand containing the same active ingredients, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.
What Is Paxlovid (Nirmatrelvir + Ritonavir)?
Paxlovid is the original brand name for the oral antiviral combination of Nirmatrelvir + Ritonavir, used in the treatment of COVID-19 in patients who are at higher risk of complications.
Nirmatrelvir belongs to a class of medicines known as SARS-CoV-2 protease inhibitors, while Ritonavir acts as a pharmacokinetic enhancer. Together, they help suppress viral multiplication in the early stage of infection.
Generic/local versions such as Bexovid 150mg+100mg contain the same active ingredients and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
Nirmatrelvir + Ritonavir is classified as an oral antiviral combination medicine with potent activity against SARS-CoV-2 when given in the early course of infection.
How Nirmatrelvir + Ritonavir Works
It works in several ways:
- Nirmatrelvir inhibits the SARS-CoV-2 main protease (Mpro/3CL protease) needed for viral replication
- Ritonavir slows the metabolism of Nirmatrelvir, increasing its blood concentration
- Helps reduce the amount of virus in the body during early infection
Through these mechanisms, this antiviral combination helps reduce disease progression in eligible COVID-19 patients.
How Paxlovid Works in the Body
COVID-19 virus needs specific enzymes to reproduce inside the body. Paxlovid works by blocking one of the virus’s essential enzymes, making it harder for the virus to multiply.
Key Actions of Nirmatrelvir + Ritonavir
- Blocking viral protease activity required for replication
- Increasing active drug exposure through Ritonavir boosting
- Helping reduce the chance of severe COVID-19 when started early
Some local brands such as Bexovid deliver the same antiviral combination, allowing similar early COVID-19 treatment when prescribed appropriately.
Medical Uses of Paxlovid (Nirmatrelvir + Ritonavir) 150mg+100mg
Paxlovid 150mg+100mg is prescribed for the treatment of mild-to-moderate COVID-19 in selected patients who are at higher risk of progression to severe disease. It should be started as early as possible after diagnosis and within the recommended treatment window.
Paxlovid for COVID-19 Treatment
This medicine is used in patients with confirmed COVID-19 who may be more vulnerable to complications because of age, underlying illness, or reduced immunity.
Potential Benefits
- Helps lower the risk of severe COVID-19 progression
- May reduce hospitalization risk in high-risk patients
- Convenient oral treatment option when used under medical supervision
Generic/local alternatives like Bexovid 150mg+100mg may also be used under medical supervision when this antiviral therapy is recommended.
Who Can Take Bexovid 150mg+100mg?
Because this antiviral medicine has important drug interaction and dosing considerations, treatment should always be supervised by a qualified healthcare provider.
Eligibility Criteria
Patients may be prescribed Paxlovid if they:
- Have mild-to-moderate COVID-19
- Are considered high risk for progression to severe disease
- Can start treatment within 5 days of symptom onset
- Are 12 years or older and weigh at least 40kg, if appropriate per prescribing guidance
Certain local options such as Bexovid may also be considered depending on availability and physician decision.
Who Should Avoid Paxlovid (Nirmatrelvir + Ritonavir) 150mg+100mg
Paxlovid should NOT be used by:
- Individuals with hypersensitivity to Nirmatrelvir or Ritonavir
- Patients taking certain medicines with serious CYP3A interactions
- Patients with severe kidney impairment unless a doctor determines otherwise
- Patients with severe liver problems, depending on clinical assessment
Paxlovid (Nirmatrelvir + Ritonavir) 150mg+100mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- 300mg Nirmatrelvir + 100mg Ritonavir twice daily for 5 days
- Treatment should begin as soon as possible after COVID-19 diagnosis
- Ideally started within 5 days of symptom onset
- Tablets may be taken with or without food
- Swallow tablets whole unless otherwise instructed by a doctor
Dosage Adjustments
Doctors may adjust the dose depending on:
- Kidney function (renal impairment)
- Current medication list due to major drug interactions
- Individual treatment suitability and tolerance
Side Effects of Paxlovid 150mg+100mg
Like all antiviral medicines, Paxlovid may cause side effects.
Common Side Effects
- Altered or bitter taste in mouth
- Diarrhea
- Muscle aches
- Mild increase in blood pressure in some patients
Serious Side Effects
- Drug Interactions: May interact with many commonly used medicines
- Liver-related effects: Caution in some patients with liver disease
- Allergic reactions: Rash, swelling, or severe hypersensitivity in rare cases
- Reduced effectiveness if started late: Best used early in illness
Patients should report any unusual symptoms to their doctor immediately.
Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Frequently Asked Questions (FAQs)
1. Is Paxlovid (Nirmatrelvir + Ritonavir) 150mg+100mg an antibiotic?
No. Paxlovid is an antiviral medicine, not an antibiotic. It is used specifically for treating COVID-19 in eligible patients.
2. When should Bexovid 150mg+100mg be started?
It should be started as early as possible after diagnosis and usually within 5 days of symptom onset.
3. Can Bexovid 150mg+100mg be taken without Ritonavir?
No. Nirmatrelvir must be taken together with Ritonavir as part of the prescribed combination.
4. Is Paxlovid (Nirmatrelvir + Ritonavir) 150mg+100mg safe for everyone with COVID-19?
No. It is mainly intended for selected high-risk patients and should only be used after medical evaluation.
5. Can pregnant women take Bexovid 150mg+100mg?
Use during pregnancy should only be considered if a doctor decides it is appropriate. Patients should always seek professional medical advice before use.
6. Is Bexovid 150mg+100mg the same as Paxlovid?
Bexovid 150mg+100mg contains Nirmatrelvir + Ritonavir, the same active ingredients used in Paxlovid. Local/generic versions may be available depending on market authorization and physician recommendation.
7. Do I need a prescription to buy Bexovid (Nirmatrelvir + Ritonavir) 150mg+100mg?
Yes. Bexovid is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
Medical Disclaimer
Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Paxlovid (Nirmatrelvir + Ritonavir) is a prescription-only medicine and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication
